• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区全民健康保险制度下前列腺癌患者的中医药使用趋势:1996-2008 年。

Trends in Chinese medicine use among prostate cancer patients under national health insurance in Taiwan: 1996-2008.

机构信息

Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.

出版信息

Integr Cancer Ther. 2011 Dec;10(4):317-27. doi: 10.1177/1534735410392576. Epub 2011 Mar 7.

DOI:10.1177/1534735410392576
PMID:21382965
Abstract

BACKGROUND

Taiwan National Health Insurance (NHI) provides Western medicine and Chinese medicine (CM). This study aims to explore the trends of CM use among prostate cancer patients under NHI.

METHODS

Claims of CM outpatient services from 1996 to 2008 were obtained from NHI Research Database. CM visits of prostate cancer patients were identified. Claims with diagnosis code of prostate cancer were defined as cancer-specific visits.

RESULTS

Among 78 323 prostate cancer patients identified during 1996-2008, there were 30 383 (38.8%) CM users and 327 063 CM outpatient visits. The prevalence of CM use in each cross-sectional year increased slightly from 24.9% to 25.6%. Most CM visits (92.7%) were non-cancer-specific. There were greater increases in the proportion of cancer-specific CM visits (from 2.3% to 10.6%) and high-utility CM users (from 3.1% to 19.7%). Most CM services were provided by private clinics (68.1% to 79.2%). The most frequently used CM therapies were Chinese herbal medicine (72.8% to 78.8%), followed by acupuncture/traumatology manipulative therapies (28.1% to 36.8%). Total CM cost increased from $122 247 to $825 454. The average cost per CM visit increased from $14.0 to $19.6. The annual cost per CM user increased from $88.0 to $134.4. Copayment accounted for 6.6% to 11.7%.

CONCLUSIONS

There was a trend of increased CM use among prostate cancer patients under NHI. Although prostate cancer patients used CM mostly for noncancer diseases, CM visits for prostate cancer increased remarkably. The utilization patterns of CM visits for cancer and for noncancer diseases were distinctly different.

摘要

背景

台湾全民健康保险(NHI)提供西医和中医(CM)服务。本研究旨在探讨 NHI 背景下前列腺癌患者使用 CM 的趋势。

方法

从 NHI 研究数据库中获取 1996 年至 2008 年的 CM 门诊服务索赔。确定前列腺癌患者的 CM 就诊次数。具有前列腺癌诊断代码的索赔被定义为癌症特异性就诊。

结果

在 1996 年至 2008 年间确定的 78323 例前列腺癌患者中,有 30383 例(38.8%)为 CM 用户,有 327063 次 CM 门诊就诊。每年 CM 使用的流行率从 24.9%略微增加到 25.6%。大多数 CM 就诊(92.7%)是非癌症特异性的。癌症特异性 CM 就诊的比例(从 2.3%增加到 10.6%)和高利用率 CM 用户(从 3.1%增加到 19.7%)增加更大。大多数 CM 服务由私人诊所提供(68.1%至 79.2%)。最常使用的 CM 疗法是中草药(72.8%至 78.8%),其次是针灸/推拿疗法(28.1%至 36.8%)。CM 总费用从 122247 美元增加到 825454 美元。每次 CM 就诊的平均费用从 14.0 美元增加到 19.6 美元。每位 CM 用户的年费用从 88.0 美元增加到 134.4 美元。共付额占 6.6%至 11.7%。

结论

NHI 背景下前列腺癌患者 CM 使用呈上升趋势。尽管前列腺癌患者主要使用 CM 治疗非癌症疾病,但用于治疗前列腺癌的 CM 就诊次数显著增加。癌症和非癌症疾病的 CM 就诊利用模式明显不同。

相似文献

1
Trends in Chinese medicine use among prostate cancer patients under national health insurance in Taiwan: 1996-2008.台湾地区全民健康保险制度下前列腺癌患者的中医药使用趋势:1996-2008 年。
Integr Cancer Ther. 2011 Dec;10(4):317-27. doi: 10.1177/1534735410392576. Epub 2011 Mar 7.
2
Use of Chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan.台湾地区一项针对乳腺癌女性使用中医药的全国性横断面研究。
Complement Ther Med. 2011 Jun;19(3):137-43. doi: 10.1016/j.ctim.2011.04.001. Epub 2011 May 2.
3
Prevalence, patterns, and costs of Chinese medicine use among prostate cancer patients: a population-based study in Taiwan.台湾地区基于人群的研究:前列腺癌患者中中医药使用的流行率、模式和费用。
Integr Cancer Ther. 2010 Mar;9(1):16-23. doi: 10.1177/1534735409359073.
4
Use of Chinese medicine among prostate cancer patients in Taiwan: a retrospective longitudinal cohort study.台湾地区前列腺癌患者使用中医药的情况:一项回顾性纵向队列研究。
Int J Urol. 2011 May;18(5):383-6. doi: 10.1111/j.1442-2042.2011.02738.x. Epub 2011 Mar 9.
5
Insurance covered and non-covered complementary and alternative medicine utilisation among adults in Taiwan.台湾成年人中保险涵盖与未涵盖的补充和替代医学使用情况。
Soc Sci Med. 2008 Oct;67(7):1183-9. doi: 10.1016/j.socscimed.2008.06.011. Epub 2008 Jul 22.
6
Patterns of traditional Chinese medicine use in patients with inflammatory bowel disease: a population study in Taiwan.炎症性肠病患者的中医用药模式:台湾的一项人群研究。
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):467-70.
7
Comparative use of biomedicine and Chinese medicine in Taiwan: using the NHI Research Database.在台湾比较使用中西医学:利用全民健康保险研究资料库。
J Altern Complement Med. 2011 Apr;17(4):339-46. doi: 10.1089/acm.2010.0200. Epub 2011 Mar 25.
8
The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.台湾地区中药产品的处方用药情况:基于全民健康保险报销数据库的横断面分析
Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):609-19. doi: 10.1002/pds.1611.
9
Prescription pattern of traditional Chinese medicine for climacteric women in Taiwan.台湾地区围绝经期妇女的中医药处方模式。
Climacteric. 2009 Dec;12(6):541-7. doi: 10.3109/13697130903060081.
10
Frequencies and prescription patterns of traditional Chinese medicine use among elderly patients in Taiwan: A population-based study.台湾老年患者中使用中医药的频率和处方模式:一项基于人群的研究。
J Ethnopharmacol. 2015 Jul 1;169:328-34. doi: 10.1016/j.jep.2015.04.046. Epub 2015 May 5.

引用本文的文献

1
Effects of Psychological Intervention on Perioperative Quality of Life and Serum PSA and FPSA Levels of Patients with Prostate Cancer Treated with Integrated Traditional Chinese and Western Medicine.心理干预对中西医结合治疗前列腺癌患者围手术期生活质量及血清前列腺特异抗原和游离前列腺特异抗原水平的影响
Evid Based Complement Alternat Med. 2021 Nov 26;2021:9286905. doi: 10.1155/2021/9286905. eCollection 2021.
2
Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.癌症患者中使用草药的患病率:一项系统评价和荟萃分析。
Evid Based Complement Alternat Med. 2021 May 17;2021:9963038. doi: 10.1155/2021/9963038. eCollection 2021.
3
Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds.
中药治疗前列腺癌:从方剂到提取物和化合物。
Nutrients. 2018 Feb 28;10(3):283. doi: 10.3390/nu10030283.
4
Use of Chinese medicine among colorectal cancer patients: a nationwide population-based study.结直肠癌患者使用中药情况:一项基于全国人群的研究。
Afr J Tradit Complement Altern Med. 2014 Jan 28;11(2):343-349. doi: 10.4314/ajtcam.v11i2.20. eCollection 2014.
5
Coprescription of Chinese Herbal Medicine and Western Medications among Prostate Cancer Patients: A Population-Based Study in Taiwan.中文草药与西药合并处方于摄护腺癌病患之研究: 以台湾族群为基础之研究。
Evid Based Complement Alternat Med. 2012;2012:147015. doi: 10.1155/2012/147015. Epub 2011 Jul 18.